A powerful combination of proprietary and industry-leading technologies to deliver ideal human and murine mAbs against traditionally difficult targets
Proprietary DiversimAb Mice
ENGINEERED, AUTO-IMMUNE MICE WITH ENHANCED EPITOPIC DIVERSITY
DiversimAb mice deliver panels of murine mAbs with superior epitopic diversity as compared to regular mice. This provides an advantage in nearly any custom mAb discovery application.
Our DiversimAb platform readily generates species cross-reactive antibodies, including human, cyno and even mouse cross-reactive clones.
Difficult High Homology Epitope Targeting
Our auto-immune, hyperimmune model enables the delivery of panels of mAbs against targets, and epitopes on those targets, that do not elicit an immune response in natural mice. We've delivered mAbs against 100% mouse proteins out of DiversimAb mice.
Optimized Immunization Strategies
DIVERSE TOOLBOX OF STRATEGIES TO GENERATE IMMUNE RESPONSE AGAINST THE TOUGHEST OF TARGETS
Rapid Immunization Timelines
Immunization strategies optimized for rapid antibody generation without sacrifices in antibody affinity or quality. Identify subnanomolar antibodies in weeks, not months.
Purpose-Built Strategies For Tough Targets
We use custom immunization protocols for multi-spanners, high homology targets, and other poor immunogens. Many options available, connect with our team to learn more.
Industry-Leading Adjuvant Formulations
Our in-house adjuvant suite is stacked with custom formulations that give us an edge for across targets and in-vivo models.
THE RIGHT TOOLS FOR THE JOB
Abveris Uses Leading Platforms For Antibody Discovery.
Spotlight: The Berkeley Lights Beacon
Single B cell screening with the highest possible resolution, throughput, and speed.